Treatment of Refractory Persistent Corneal Epithelial Defects: A Standardized Approach Using Continuous Wear PROSE Therapy.
Ocul Immunol Inflamm
; 23(3): 219-24, 2015 Jun.
Article
em En
| MEDLINE
| ID: mdl-24654929
ABSTRACT
PURPOSE:
To evaluate continuous wear of a fluid-ventilated, gas-permeable scleral PROSE device using a standardized protocol as treatment for refractory persistent corneal epithelial defects in patients with severe ocular surface disease.METHODS:
Retrospective review of eight eyes of seven consecutive patients with persistent epithelial defects refractory to traditional therapies. The standardized treatment regimen consisted of (1) 24-hour-a-day PROSE wear until re-epithelialization was achieved, (2) brief daily device removal, cleaning, disinfection, and reservoir fluid replacement, (3) addition of a benzalkonium chloride (BAK)-free fourth-generation fluoroquinolone antibiotic drop to the reservoir, and (4) transition to long-term, daytime PROSE wear upon re-epithelialization.RESULTS:
All eight eyes exhibited resolution of the persistent epithelial defect. No eyes developed microbial keratitis. Four eyes exhibited recurrences; all recurrences promptly responded to reinstitution of continuous wear.CONCLUSIONS:
Continuous wear of a PROSE device, using a strictly standardized regimen, constitutes an effective, safe treatment option for refractory persistent epithelial defects.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Lentes de Contato de Uso Prolongado
/
Epitélio Corneano
/
Doenças da Córnea
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article